Functional visual field and navigation testing for moderate-to-profound inherited retinal disease
Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
This project will test whether functional visual field and navigation tests can measure real-world vision and mobility in people with moderate-to-profound inherited retinal diseases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ray Therapeutics, Inc. Industry-sponsored |
| Locations | 1 site (Irvine, California) |
| Trial ID | NCT07502664 on ClinicalTrials.gov |
What this trial studies
This observational, non-interventional project enrolls people with moderate-to-profound inherited retinal diseases to test and refine visual function endpoints focused on peripheral vision. Participants complete a battery of standardized tasks that measure spatial orientation, mobility, wayfinding, and related functional vision in controlled settings at the Vision Research and Assessment Institute in Irvine, CA. The study emphasizes operational feasibility and measurement properties such as reliability, sensitivity to change, and real-world relevance. Findings will inform selection of endpoints for future therapeutic trials in low-vision populations.
Who should consider this trial
Good fit: Ideal candidates are adults with bilateral retinitis pigmentosa or other retinal dystrophies affecting peripheral vision, best-corrected visual acuity between 20/200 and hand motions in at least one eye, and the ability to communicate in English or Spanish and complete in-person testing.
Not a fit: Patients with primarily central-only vision loss outside the stated acuity range, significant cognitive impairment that prevents test completion, current pregnancy, or inability to travel to the study site are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the refined endpoints could help clinical trials detect meaningful changes in mobility and peripheral vision and speed development of therapies for low-vision conditions.
How similar studies have performed: Related mobility and navigation outcome measures have been used in prior low-vision research and shown promise, but standardized, regulatory-ready endpoints for peripheral function and wayfinding remain under development.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of bilateral retinitis pigmentosa (RP) or other retinal dystrophies impacting peripheral vision as confirmed from previous eye examination records * Best-corrected visual acuity between 20/200 to HM in at least one eye. * Reasonably fluent in English or Spanish Exclusion Criteria: * Cognitive impairment, memory loss or dementia sufficient in severity to preclude informed consent or in the opinion of the investigator would prevent satisfactory completion of some or all of the testing. * Any circumstance that in the opinion of the investigator, would interfere with participation in, or compliance with the study protocol * Current pregnancy as reported by patient
Where this trial is running
Irvine, California
- Vision Research and Assessment Institute — Irvine, California, United States (Recruiting)
Study contacts
- Study coordinator: Reem Jaber, MS, CGC
- Email: info@vr-ai.com
- Phone: 949-264-3793
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.